Riskpilot← Back to searchSign inGet full accessScandinavian Biopharma Distribution AB
ABActiveOrg 5568458995Industrivägen 1 4trWholesale of pharmaceutical and medical goods · NACE 4646Est. 20111-4 employees
Revenue 2024
SEK 157,1M
+2% vs 2023
EBITDA margin
17.4%
-10% vs 2023
Equity ratio
1.3%
Financial strength
Net profit 2024
SEK 45K
+165% vs 2023
| Revenue | SEK 157,1M | +2% |
| EBITDA | SEK 27,3M | -10% |
| Net profit | SEK 45K | +165% |
| Total assets | SEK 78,8M | -6% |
| Equity | SEK 1M | +5% |
| Employees | — | — |
Legal name
Scandinavian Biopharma Distribution AB
Org number
5568458995
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 mars 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Bengtsson, Pehr Jonas Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska distriburera, marknadsföra och försälja läkemedel och andra sjuk- eller hälsovårdsrelaterade produkter samt därmed förenlig verksamhet.
Address
Industrivägen 1 4tr
Phone
+4684705600
Email
bjorn.sjostrand@sbdistribution.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 82 139 | 94 302 | 121 790 | 154 382 | 157 077 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 15 232 | 21 617 | 32 206 | 30 409 | 27 272 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 15 232 | 21 617 | 32 206 | 30 409 | 27 272 |
| Net financials | −41 | −385 | −934 | −58 | −597 |
| Profit before tax | 10 | 61 | 174 | 155 | 245 |
| Tax | −6 | −57 | −158 | −138 | −200 |
| Net profit | 4 | 4 | 16 | 17 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 76 396 | 44 754 | 67 706 | 83 513 | 78 818 |
| Equity | 928 | 933 | 948 | 965 | 1 010 |
| Long-term debt | 53 541 | 26 493 | 38 752 | 55 942 | 55 950 |
| Short-term debt | 21 927 | 17 328 | 28 006 | 26 606 | 21 858 |
| Total debt | 75 468 | 43 821 | 66 758 | 82 548 | 77 808 |
EBITDA margin
17.4%
This company
15.8%
Market median
+10% vs market
20202024
Equity ratio
1.3%
This company
38.2%
Market median
-97% vs market
20202024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
1.99×
This company
1.12×
Market median
+78% vs market
20202024
Debt / equity
77.04×
This company
0.62×
Market median
-12326% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
BM Chief Executive Officer | Chief Executive Officer | 2022 |
AM Chief Auditor | Chief Auditor | 2022 |
PJ External Signatory | External Signatory | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scandinavian Biopharma Holding AB
Scandinavian Biopharma Distribution AB (this company)SCANDINAVIAN BIOPHARMA DISTRIBUTION APSScandinavian Biopharma Distribution ApsBoard members of Scandinavian Biopharma Distribution AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Magnus Sjöstrand | Chief Executive Officer | 0 companies |
| Anna Maria Wretholm | Chief Auditor | 0 companies |
| Pehr Jonas Bengtsson | External Signatory | 0 companies |
| Ingrid Anette Elmqvist | Board of Directors | 0 companies |
| Nils Ivar Arne Carlin | Board of Directors | 0 companies |
| Mats Olof Magnus Lidgard | Chairman | 0 companies |